- Home
- ZLAB vs UAA Comparison
ZLAB vs UAA Comparison
Compare ZLAB & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- UAA
- Stock Information
- Founded
- ZLAB 2013
- UAA 1996
- Country
- ZLAB China
- UAA United States
- Employees
- ZLAB N/A
- UAA N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- UAA Apparel
- Sector
- ZLAB Health Care
- UAA Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- UAA Nasdaq
- Market Cap
- ZLAB 3.6B
- UAA 2.9B
- IPO Year
- ZLAB 2017
- UAA N/A
- Fundamental
- Price
- ZLAB $33.57
- UAA $6.86
- Analyst Decision
- ZLAB Buy
- UAA Hold
- Analyst Count
- ZLAB 5
- UAA 19
- Target Price
- ZLAB $54.28
- UAA $7.25
- AVG Volume (30 Days)
- ZLAB 718.8K
- UAA 10.3M
- Earning Date
- ZLAB 08-07-2025
- UAA 08-07-2025
- Dividend Yield
- ZLAB N/A
- UAA N/A
- EPS Growth
- ZLAB N/A
- UAA N/A
- EPS
- ZLAB N/A
- UAA N/A
- Revenue
- ZLAB $418,326,000.00
- UAA $5,164,310,000.00
- Revenue This Year
- ZLAB $44.07
- UAA N/A
- Revenue Next Year
- ZLAB $49.13
- UAA $2.91
- P/E Ratio
- ZLAB N/A
- UAA N/A
- Revenue Growth
- ZLAB 43.72
- UAA N/A
- 52 Week Low
- ZLAB $16.01
- UAA $4.78
- 52 Week High
- ZLAB $44.34
- UAA $11.89
- Technical
- Relative Strength Index (RSI)
- ZLAB 44.39
- UAA 50.94
- Support Level
- ZLAB $32.31
- UAA $6.59
- Resistance Level
- ZLAB $36.53
- UAA $7.10
- Average True Range (ATR)
- ZLAB 1.11
- UAA 0.28
- MACD
- ZLAB -0.20
- UAA -0.04
- Stochastic Oscillator
- ZLAB 27.12
- UAA 32.53
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.